Selected research
Market Structure
Global DNA & RNA Oligonucleotides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global DNA & RNA Oligonucleotides market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for DNA & RNA Oligonucleotides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for DNA & RNA Oligonucleotides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for DNA & RNA Oligonucleotides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for DNA & RNA Oligonucleotides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of DNA & RNA Oligonucleotides include Berry Genomics, BGI, Brooks Life Sciences, Dna Link, Eurofins Scientific, Genotypic Technology, Illumina, LabCorp and Macrogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global DNA & RNA Oligonucleotides market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of DNA & RNA Oligonucleotides and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents DNA & RNA Oligonucleotides revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the DNA & RNA Oligonucleotides market size, projected growth trends, production technologies, key applications, and end-use industries.
DNA & RNA Oligonucleotides Segment by Company
Berry Genomics
BGI
Brooks Life Sciences
Dna Link
Eurofins Scientific
Genotypic Technology
Illumina
LabCorp
Macrogen
Natera
Roche
DNA & RNA Oligonucleotides Segment by Type
DNA Oligonucleotides
RNA Oligonucleotides
DNA & RNA Oligonucleotides Segment by Application
Biopharma Companies
Academic & Research Organizations
Hospitals and Clinics
Others
DNA & RNA Oligonucleotides Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA & RNA Oligonucleotides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA & RNA Oligonucleotides and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA & RNA Oligonucleotides.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of DNA & RNA Oligonucleotides in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA & RNA Oligonucleotides industry.
Chapter 3: Detailed analysis of DNA & RNA Oligonucleotides companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA & RNA Oligonucleotidesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Oligonucleotides
- RNA Oligonucleotides
Applications
- Biopharma Companies
- Academic & Research Organizations
- Hospitals and Clinics
- Others
Companies covered
- Berry Genomics
- BGI
- Brooks Life Sciences
- Dna Link
- Eurofins Scientific
- Genotypic Technology
- Illumina
- LabCorp
- Macrogen
- Natera
- Roche
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 DNA Oligonucleotides
- 1.2.3 RNA Oligonucleotides
- 1.3 Market Analysis by Application
- 1.3.1 Global DNA & RNA Oligonucleotides Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Biopharma Companies
- 1.3.3 Academic & Research Organizations
- 1.3.4 Hospitals and Clinics
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global DNA & RNA Oligonucleotides Growth Trends by Region
- 1.5.1 Global DNA & RNA Oligonucleotides Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 DNA & RNA Oligonucleotides Market Size by Region (2021-2026)
- 1.5.3 DNA & RNA Oligonucleotides Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global DNA & RNA Oligonucleotides Market Dynamics
- 2.1 DNA & RNA Oligonucleotides Industry Trends
- 2.2 DNA & RNA Oligonucleotides Industry Drivers
- 2.3 DNA & RNA Oligonucleotides Industry Opportunities and Challenges
- 2.4 DNA & RNA Oligonucleotides Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global DNA & RNA Oligonucleotides Revenue by Company (2021-2026)
- 3.2 Global DNA & RNA Oligonucleotides Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global DNA & RNA Oligonucleotides Key Company Head office and Area Served
- 3.4 Global DNA & RNA Oligonucleotides Company, Product Type & Application
- 3.5 Global DNA & RNA Oligonucleotides Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global DNA & RNA Oligonucleotides Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 DNA & RNA Oligonucleotides Players Market Share by Revenue in 2025
- 3.6.3 2025 DNA & RNA Oligonucleotides Tier 1, Tier 2, and Tier 3
4 DNA & RNA Oligonucleotides Market by Type
- 4.1 Global DNA & RNA Oligonucleotides Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global DNA & RNA Oligonucleotides Market Size by Type (2021-2032)
- 4.3 Global DNA & RNA Oligonucleotides Market Size Share by Type (2021-2032)
5 DNA & RNA Oligonucleotides Market by Application
- 5.1 Global DNA & RNA Oligonucleotides Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global DNA & RNA Oligonucleotides Market Size by Application (2021-2032)
- 5.3 Global DNA & RNA Oligonucleotides Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Berry Genomics
- 6.1.1 Berry Genomics Company Information
- 6.1.2 Berry Genomics Business Overview
- 6.1.3 Berry Genomics DNA & RNA Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Berry Genomics DNA & RNA Oligonucleotides Product Portfolio
- 6.1.5 Berry Genomics Recent Developments
- 6.2 BGI
- 6.2.1 BGI Company Information
- 6.2.2 BGI Business Overview
- 6.2.3 BGI DNA & RNA Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 BGI DNA & RNA Oligonucleotides Product Portfolio
- 6.2.5 BGI Recent Developments
- 6.3 Brooks Life Sciences
- 6.3.1 Brooks Life Sciences Company Information
- 6.3.2 Brooks Life Sciences Business Overview
- 6.3.3 Brooks Life Sciences DNA & RNA Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Brooks Life Sciences DNA & RNA Oligonucleotides Product Portfolio
- 6.3.5 Brooks Life Sciences Recent Developments
- 6.4 Dna Link
- 6.4.1 Dna Link Company Information
- 6.4.2 Dna Link Business Overview
- 6.4.3 Dna Link DNA & RNA Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Dna Link DNA & RNA Oligonucleotides Product Portfolio
- 6.4.5 Dna Link Recent Developments
- 6.5 Eurofins Scientific
- 6.5.1 Eurofins Scientific Company Information
- 6.5.2 Eurofins Scientific Business Overview
- 6.5.3 Eurofins Scientific DNA & RNA Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Eurofins Scientific DNA & RNA Oligonucleotides Product Portfolio
- 6.5.5 Eurofins Scientific Recent Developments
- 6.6 Genotypic Technology
- 6.6.1 Genotypic Technology Company Information
- 6.6.2 Genotypic Technology Business Overview
- 6.6.3 Genotypic Technology DNA & RNA Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Genotypic Technology DNA & RNA Oligonucleotides Product Portfolio
- 6.6.5 Genotypic Technology Recent Developments
- 6.7 Illumina
- 6.7.1 Illumina Company Information
- 6.7.2 Illumina Business Overview
- 6.7.3 Illumina DNA & RNA Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Illumina DNA & RNA Oligonucleotides Product Portfolio
- 6.7.5 Illumina Recent Developments
- 6.8 LabCorp
- 6.8.1 LabCorp Company Information
- 6.8.2 LabCorp Business Overview
- 6.8.3 LabCorp DNA & RNA Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 LabCorp DNA & RNA Oligonucleotides Product Portfolio
- 6.8.5 LabCorp Recent Developments
- 6.9 Macrogen
- 6.9.1 Macrogen Company Information
- 6.9.2 Macrogen Business Overview
- 6.9.3 Macrogen DNA & RNA Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Macrogen DNA & RNA Oligonucleotides Product Portfolio
- 6.9.5 Macrogen Recent Developments
- 6.10 Natera
- 6.10.1 Natera Company Information
- 6.10.2 Natera Business Overview
- 6.10.3 Natera DNA & RNA Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Natera DNA & RNA Oligonucleotides Product Portfolio
- 6.10.5 Natera Recent Developments
- 6.11 Roche
- 6.11.1 Roche Company Information
- 6.11.2 Roche Business Overview
- 6.11.3 Roche DNA & RNA Oligonucleotides Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Roche DNA & RNA Oligonucleotides Product Portfolio
- 6.11.5 Roche Recent Developments
7 North America
- 7.1 North America DNA & RNA Oligonucleotides Market Size (2021-2032)
- 7.2 North America DNA & RNA Oligonucleotides Market Size by Type
- 7.2.1 North America DNA & RNA Oligonucleotides Market Size by Type (2021-2026)
- 7.2.2 North America DNA & RNA Oligonucleotides Market Size by Type (2027-2032)
- 7.2.3 North America DNA & RNA Oligonucleotides Market Share by Type (2021-2032)
- 7.3 North America DNA & RNA Oligonucleotides Market Size by Application
- 7.3.1 North America DNA & RNA Oligonucleotides Market Size by Application (2021-2026)
- 7.3.2 North America DNA & RNA Oligonucleotides Market Size by Application (2027-2032)
- 7.3.3 North America DNA & RNA Oligonucleotides Market Share by Application (2021-2032)
- 7.4 North America DNA & RNA Oligonucleotides Market Size by Country
- 7.4.1 North America DNA & RNA Oligonucleotides Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America DNA & RNA Oligonucleotides Market Size by Country (2021-2026)
- 7.4.3 North America DNA & RNA Oligonucleotides Market Size by Country (2027-2032)
- 7.4.4 North America DNA & RNA Oligonucleotides Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe DNA & RNA Oligonucleotides Market Size (2021-2032)
- 8.2 Europe DNA & RNA Oligonucleotides Market Size by Type
- 8.2.1 Europe DNA & RNA Oligonucleotides Market Size by Type (2021-2026)
- 8.2.2 Europe DNA & RNA Oligonucleotides Market Size by Type (2027-2032)
- 8.2.3 Europe DNA & RNA Oligonucleotides Market Share by Type (2021-2032)
- 8.3 Europe DNA & RNA Oligonucleotides Market Size by Application
- 8.3.1 Europe DNA & RNA Oligonucleotides Market Size by Application (2021-2026)
- 8.3.2 Europe DNA & RNA Oligonucleotides Market Size by Application (2027-2032)
- 8.3.3 Europe DNA & RNA Oligonucleotides Market Share by Application (2021-2032)
- 8.4 Europe DNA & RNA Oligonucleotides Market Size by Country
- 8.4.1 Europe DNA & RNA Oligonucleotides Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe DNA & RNA Oligonucleotides Market Size by Country (2021-2026)
- 8.4.3 Europe DNA & RNA Oligonucleotides Market Size by Country (2027-2032)
- 8.4.4 Europe DNA & RNA Oligonucleotides Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China DNA & RNA Oligonucleotides Market Size (2021-2032)
- 9.2 China DNA & RNA Oligonucleotides Market Size by Type
- 9.2.1 China DNA & RNA Oligonucleotides Market Size by Type (2021-2026)
- 9.2.2 China DNA & RNA Oligonucleotides Market Size by Type (2027-2032)
- 9.2.3 China DNA & RNA Oligonucleotides Market Share by Type (2021-2032)
- 9.3 China DNA & RNA Oligonucleotides Market Size by Application
- 9.3.1 China DNA & RNA Oligonucleotides Market Size by Application (2021-2026)
- 9.3.2 China DNA & RNA Oligonucleotides Market Size by Application (2027-2032)
- 9.3.3 China DNA & RNA Oligonucleotides Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia DNA & RNA Oligonucleotides Market Size (2021-2032)
- 10.2 Asia DNA & RNA Oligonucleotides Market Size by Type
- 10.2.1 Asia DNA & RNA Oligonucleotides Market Size by Type (2021-2026)
- 10.2.2 Asia DNA & RNA Oligonucleotides Market Size by Type (2027-2032)
- 10.2.3 Asia DNA & RNA Oligonucleotides Market Share by Type (2021-2032)
- 10.3 Asia DNA & RNA Oligonucleotides Market Size by Application
- 10.3.1 Asia DNA & RNA Oligonucleotides Market Size by Application (2021-2026)
- 10.3.2 Asia DNA & RNA Oligonucleotides Market Size by Application (2027-2032)
- 10.3.3 Asia DNA & RNA Oligonucleotides Market Share by Application (2021-2032)
- 10.4 Asia DNA & RNA Oligonucleotides Market Size by Country
- 10.4.1 Asia DNA & RNA Oligonucleotides Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia DNA & RNA Oligonucleotides Market Size by Country (2021-2026)
- 10.4.3 Asia DNA & RNA Oligonucleotides Market Size by Country (2027-2032)
- 10.4.4 Asia DNA & RNA Oligonucleotides Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Size (2021-2032)
- 11.2 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type
- 11.2.1 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application
- 11.3.1 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country
- 11.4.1 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa DNA & RNA Oligonucleotides Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst